Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma.

Cancers (Basel) · 2021 · PMC8074251 · PMID 33924080

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

nearly statistically significantp = 0.06so close (0.05 < p ≤ 0.1)

However, patients without a CDKN2A deletion/mutation or CDK4 amplification had nearly statistically significant, longer OS compared to patients with a CDKN2A deletion/mutation or CDK4 amplification (17.6 versus 10.1 months, Figure 3 , p = 0.06).

also in 323 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.